Carlson Capital, L.P.’s Trillium Therapeutics Inc Position
Does Carlson Capital, L.P. own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 900.0K shares worth $16M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$16M
Q3 2021
Shares
900.0K
% of Portfolio
+0.83%
Quarters Held
1
position exited
Position History TREUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2021 | 900.0K | $16M | +0.83% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of TREUR.